Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit
Mascarella, M.; Olonisakin, T.; Rumde, P.; Vendra, V.; Nance, M.; Kim, S.; Kubik, M.; Sridharan, S.; Ferris, R.; Moon, F.; Clayburgh, D.; Ohr, J.; Joyce, S.; Sen, M.; Herman, J.; Grandis, J.; Zandberg, D.; Duvvuri, U.
SCOPUS:85140474367
ISSN: 0959-8049
CID: 5487802